About
Technology
Issues
FAQ
Links
Official Page
Long‐term responses in patients with recurring or refractory B‐cell non‐Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.